日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical synergistic effects when combining a radiolabelled HER2-targeting single domain antibody with PARP inhibitor Olaparib

将放射性标记的靶向 HER2 的单域抗体与 PARP 抑制剂奥拉帕尼联合使用,可产生临床前协同效应。

Dewulf, Jonatan; Navarro, Laurent; Dumauthioz, Nina; Berdal, Marion; Nagachinta, Surasa; Gaspariunaite, Vaiva; Pombo Antunes, Ana Rita; Lahoutte, Tony; Massa, Sam; Devoogdt, Nick; D'Huyvetter, Matthias

Immune modulation following α and β(-) radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model

在临床前肿瘤模型中,靶向成纤维细胞活化蛋白-α的α和β(-)放射性核素治疗后的免疫调节

Ceuppens, Hannelore; De Ridder, Kirsten; Ertveldt, Thomas; Zeven, Katty; De Mey, Wout; Pombo Antunes, Ana Rita; Navarro, Laurent; Dumauthioz, Nina; Lahoutte, Tony; Debacker, Jens M; Devoogdt, Nick; Keyaerts, Marleen; D'Huyvetter, Matthias; Goyvaerts, Cleo; Breckpot, Karine

Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumors

针对HER2阳性实体瘤的纳米抗体CAR-T细胞的临床前开发和筛选

Meeus, Fien; Van der Vreken, Arne; Autaers, Dorien; De Groof, Timo W M; Esprit, Arthur; Franceschini, Lorenzo; Parone, Philippe; Goyvaerts, Cleo; De Vlaeminck, Yannick; Devoogdt, Nick; Breckpot, Karine

Design and Preclinical Validation of an Anti-B7-H3-Specific Radiotracer: A Non-Invasive Imaging Tool to Guide B7-H3-Targeted Therapies

抗B7-H3特异性放射性示踪剂的设计与临床前验证:一种指导B7-H3靶向治疗的非侵入性成像工具

Funeh, Cyprine Neba; Meeus, Fien; Van Winnendael, Niels; De Groof, Timo W M; D'Huyvetter, Matthias; Devoogdt, Nick

VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal Cavity

表达VSIG4的巨噬细胞在腹腔内发挥抗寄生虫和抗转移作用

Lebegge, Els; Kancheva, Daliya; Van Craenenbroeck, Jolien; Ernst, Sam; Bardet, Pauline M R; Caro, Aarushi A; Kiss, Máté; Jumapili, Neema Ahishakiye; Barthelmess, Romina Mora; Zivalj, Maida; Assaf, Naela; Ali, Leen; Elkrim, Yvon; Demuytere, Jesse; De Jonge, Jan; Raes, Geert; Hadadi, Eva; Devoogdt, Nick; Vincke, Cécile; Mohavedi, Kiavash; Vereecke, Lars; Ceelen, Wim; Stijlemans, Benoit; Laoui, Damya; Arnouk, Sana M; Van Ginderachter, Jo A

Nanobody-based Pannexin1 channel inhibitors increase survival after cardiac ischemia/reperfusion

基于纳米抗体的Pannexin1通道抑制剂可提高心肌缺血/再灌注后的存活率。

Rusiecka, Olga M; Molica, Filippo; Clochard, Linda; Van Campenhout, Raf; De Groof, Timo W M; Bes, Viviane; Devoogdt, Nick; Muyldermans, Serge; Vinken, Mathieu; Kwak, Brenda R

Generation and Characterization of Novel Pan-Cancer Anti-uPAR Fluorescent Nanobodies as Tools for Image-Guided Surgery

新型泛癌抗uPAR荧光纳米抗体的制备与表征及其在图像引导手术中的应用

Mateusiak, Łukasz; Floru, Sam; De Groof, Timo W M; Wouters, Janne; Declerck, Noemi B; Debie, Pieterjan; Janssen, Simone; Zeven, Katty; Puttemans, Janik; Vincke, Cécile; Breckpot, Karine; Devoogdt, Nick; Hernot, Sophie

AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies

AXL作为急性髓系白血病免疫调节因子和治疗靶点:从当前进展到新型策略

Vandewalle, Niels; De Beule, Nathan; De Becker, Ann; De Bruyne, Elke; Menu, Eline; Vanderkerken, Karin; Breckpot, Karine; Devoogdt, Nick; De Veirman, Kim

Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity

针对胶质母细胞瘤的抗原敏感型B7-H3靶向纳米抗体CAR-T细胞的临床前评估提示,可能存在靶向肿瘤外毒性。

Meeus, Fien; Funeh, Cyprine Neba; Awad, Robin Maximilian; Zeven, Katty; Autaers, Dorien; De Becker, Ann; Van Riet, Ivan; Goyvaerts, Cleo; Tuyaerts, Sandra; Neyns, Bart; Devoogdt, Nick; De Vlaeminck, Yannick; Breckpot, Karine

Imaging of tumor-associated macrophage dynamics during immunotherapy using a CD163-specific nanobody-based immunotracer

利用基于 CD163 特异性纳米抗体的免疫示踪剂对免疫治疗期间肿瘤相关巨噬细胞的动态变化进行成像

Lauwers, Yoline; De Groof, Timo W M; Vincke, Cécile; Van Craenenbroeck, Jolien; Jumapili, Neema Ahishakiye; Barthelmess, Romina Mora; Courtoy, Guillaume; Waelput, Wim; De Pauw, Tessa; Raes, Geert; Devoogdt, Nick; Van Ginderachter, Jo A